Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Mulvihill, Michael S ^a   Kwon, Yong Won ^c   Lee, Sharon ^a   Fang, Li Tai ^a   Choi, Helen ^a,b   Ray, Roshni ^a   Kang, Hio Chung ^b   Mao, Jian Hua ^c   Jablons, David ^a,b   Kim, Il Jin ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GREMLIN PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENICITY; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; GENE; GENETIC ANALYSIS; GENETIC TRANSFECTION; GREM1 GENE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROBLAST; LUNG SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS;

ADENOCARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; NEOPLASM PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY MUCOSA; RNA, MESSENGER; RNA, NEOPLASM;

EID: 84864749532     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042264     Document Type: Article

References (40)

1. Weinberg RA, (1994) Oncogenes and tumor suppressor genes. CA: A Cancer Journal for Clinicians 44: 160-170.
2. Michos O, Panman L, Vintersten K, Beier K, Zeller R, et al. (2004) Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 131: 3401-3410.
3. Bishop JM, (1991) Molecular themes in oncogenesis. Cell 64: 235-248.
4. Croce CM, (2008) Oncogenes and Cancer. New England Journal of Medicine 358: 502-511.
5. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455: 1069-1075.
6. Pao W, Miller VA, Politi KA, Riely GJ, Somwar R, et al. (2005) Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain. PLoS Med 2: e73.
7. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, et al. (2007) Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448: 561-566.
8. Kwak EL, Bang Y-J, Camidge DR, Shaw AT, Solomon B, et al. (2010) Anaplastic Lymphoma Kinase Inhibition in Non Small-Cell Lung Cancer. New England Journal of Medicine 363: 1693-1703.
9. Landi MT, Dracheva T, Rotunno M, Figueroa JD, Liu H, et al. (2008) Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival. PLoS ONE 3: e1651.
10. Su LJ, Chang CW, Wu YC, Chen KC, Lin CJ, et al. (2007) Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC Genomics 8: 140.
11. Topol L, Marx M, Laugier D, Bogdanova N, Boubnov N, et al. (1997) Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture. Mol Cell Biol 17: 4801-4810.
12. Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM, (1998) The Xenopus Dorsalizing Factor Gremlin Identifies a Novel Family of Secreted Proteins that Antagonize BMP Activities. Molecular Cell 1: 673-683.
13. Pearce JJH, Penny G, Rossant J, (1999) A Mouse Cerberus/Dan-Related Gene Family. Developmental Biology 209: 98-110.
14. Zuniga A, Haramis A-PG, McMahon AP, Zeller R, (1999) Signal relay by BMP antagonism controls the SHH/FGF4 feedback loop in vertebrate limb buds. Nature 401: 598-602.
15. Merino R, Rodriguez-Leon J, Macias D, Ganan Y, Economides AN, et al. (1999) The BMP antagonist Gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limb. Development 126: 5515-5522.
16. Capdevila J, Tsukui T, Esteban CnRg, Zappavigna V, Belmonte JCIa, (1999) Control of Vertebrate Limb Outgrowth by the Proximal Factor Meis2 and Distal Antagonism of BMPs by Gremlin. Molecular Cell 4: 839-849.
17. Shi W, Zhao J, Anderson KD, Warburton D, (2001) Gremlin negatively modulates BMP-4 induction of embryonic mouse lung branching morphogenesis. American Journal of Physiology- Lung Cellular and Molecular Physiology 280: L1030-L1039.
18. Weaver M, Yingling JM, Dunn NR, Bellusci S, Hogan BL, (1999) Bmp signaling regulates proximal-distal differentiation of endoderm in mouse lung development. Development 126: 4005-4015.
19. Lu MM, Yang H, Zhang L, Shu W, Blair DG, et al. (2001) The bone morphogenic protein antagonist gremlin regulates proximal-distal patterning of the lung. Developmental Dynamics 222: 667-680.
20. Topol LZ, Modi WS, Koochekpour S, Blair DG, (2000) DRM/GREMLIN (CKTSF1B1) maps to human chromosome 15 and is highly expressed in adult and fetal brain. Cytogenet Cell Genet 89: 79-84.
21. Chen B, Athanasiou M, Gu Q, Blair DG, (2002) Drm/Gremlin transcriptionally activates p21(Cip1) via a novel mechanism and inhibits neoplastic transformation. Biochem Biophys Res Commun 295: 1135-1141.
22. Sun L, Hui A-M, Su Q, Vortmeyer A, Kotliarov Y, et al. (2006) Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9: 287-300.
23. Sneddon JB, Zhen HH, Montgomery K, van de Rijn M, Tward AD, et al. (2006) Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proceedings of the National Academy of Sciences 103: 14842-14847.
24. Namkoong H, Shin S, Kim H, Ha S-A, Cho G, et al. (2006) The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein. BMC Cancer 6: 74.
25. Wang DJ, Zhi XY, Zhang SC, Jiang M, Liu P, et al. (2011) The bone morphogenetic protein antagonist Gremlin is overexpressed in human malignant mesothelioma. Oncol Rep.
26. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, et al. (2001) Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proceedings of the National Academy of Sciences 98: 13790-13795.
27. Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, et al. (2001) Diversity of gene expression in adenocarcinoma of the lung. Proceedings of the National Academy of Sciences 98: 13784-13789.
28. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 127: 2893-2917.
29. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, et al. (2010) SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute.
30. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer Statistics, 2010. CA: A Cancer Journal for Clinicians 60: 277-300.
31. Kelsey CR, Marks LB, Hollis D, Hubbs JL, Ready NE, et al. (2009) Local recurrence after surgery for early stage lung cancer. Cancer 115: 5218-5227.
32. Hou J, Aerts J, den Hamer B, van Ijcken W, den Bakker M, et al. (2010) Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction. PLoS ONE 5: e10312.
33. Singh A, Morris RJ, (2010) The Yin and Yang of bone morphogenetic proteins in cancer. Cytokine & Growth Factor Reviews 21: 299-313.
34. Buckley S, Shi W, Driscoll B, Ferrario A, Anderson K, et al. (2004) BMP4 signaling induces senescence and modulates the oncogenic phenotype of A549 lung adenocarcinoma cells. American Journal of Physiology- Lung Cellular and Molecular Physiology 286: L81-L86.
35. Langenfeld EM, Kong Y, Langenfeld J, (2005) Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1//5. Oncogene 25: 685-692.
36. Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, et al. (2003) The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 24: 1445-1454.
37. Mitola S, Ravelli C, Moroni E, Salvi V, Leali D, et al. (2010) Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2. Blood 116: 3677-3680.
38. Stabile H, Mitola S, Moroni E, Belleri M, Nicoli S, et al. (2007) Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood 109: 1834-1840.
39. Costello CM, Howell K, Cahill E, McBryan J, Konigshoff M, et al. (2008) Lung-selective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertension. American Journal of Physiology- Lung Cellular and Molecular Physiology 295: L272-L284.
40. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative CT method. Nat Protocols 3: 1101-1108.